Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)

Market Cap	43.35B +45.5%
Revenue (ttm)	6.93B +16.6%
Net Income	1.11B +11.7%
EPS	3.11 +10.0%
Shares Out	359.72M
PE Ratio	39.84
Forward PE	30.25
Dividend	1.30 (1.05%)
Ex-Dividend Date	Jun 26, 2025

Volume	7,194,551
Open	113.50
Previous Close	115.00
Day's Range	113.50 - 124.78
52-Week Range	81.91 - 132.98
Beta	0.11
Analysts	Buy
Price Target	145.78 (+17.74%)
Earnings Date	Aug 27, 2026

About SHE:002821

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, anti-infective, cardiovascular, and diabetes; chemical macromolecule CDMO; biomacromolecule CDMO, including antibody-peptide conjugates; formulation CDMO; clinical CRO; synthetic biology and new technology output business. The company also engages in ke...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 10,617
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002821

Financial Performance

In 2025, SHE:002821's revenue was 6.67 billion, an increase of 14.91% compared to the previous year's 5.80 billion. Earnings were 1.13 billion, an increase of 19.35%.

Analyst Summary

According to 13 analysts, the average rating for 002821 stock is "Buy." The 12-month stock price target is ¥145.78, which is an increase of 17.74% from the latest price.

Price Target

¥145.78

(17.74% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 19, 2026

Data Sources Report a data error